Literature DB >> 2788062

BGP (osteocalcin, bone-Gla-protein) in involutional osteoporosis.

A Rapado1, C de la Piedra, R Torres.   

Abstract

The role of BGP (osteocalcin) as bone marker in the study and management control of involutional osteoporosis is emphasized and the different radioimmunoassays and their limitations are commented. Our results showed significantly lower sBGP levels in osteoporotic patients compared with control group and a positive linear correlation was found between sBGP and serum alkaline phosphatase but no correlation was obtained with urinary hydroxyproline/creatinine ratio, serum tartrate-resistant acid phosphatase or bone mineral content measured by dual photon absorptiometry.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2788062     DOI： 10.1007/bf02207230

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  13 in total

1.  Serum bone gla protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis.

Authors:  F Ismail; S Epstein; R Pacifici; D Droke; S B Thomas; L V Avioli
Journal:  Calcif Tissue Int       Date:  1986-10       Impact factor: 4.333

2.  Immunochemical studies of conformational alterations in bone gamma-carboxyglutamic acid containing protein.

Authors:  P D Delmas; D D Stenner; R W Romberg; B L Riggs; K G Mann
Journal:  Biochemistry       Date:  1984-09-25       Impact factor: 3.162

3.  Radioimmunoassay for human osteocalcin using an antibody raised against the synthetic human (h37-49) sequence.

Authors:  H Jüppner; T Schettler; G Giebel; S Wenner; R D Hesch
Journal:  Calcif Tissue Int       Date:  1986-11       Impact factor: 4.333

4.  Determinants of bone gamma-carboxyglutamic acid-containing protein in plasma of healthy aging subjects.

Authors:  B D Catherwood; R Marcus; P Madvig; A K Cheung
Journal:  Bone       Date:  1985       Impact factor: 4.398

5.  Short-term 1,25-dihydroxyvitamin D3 administration raises serum osteocalcin in patients with postmenopausal osteoporosis.

Authors:  J E Zerwekh; K Sakhaee; C Y Pak
Journal:  J Clin Endocrinol Metab       Date:  1985-03       Impact factor: 5.958

6.  Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma.

Authors:  P A Price; S K Nishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

7.  [Osteocalcin and bone histology in osteoporosis].

Authors:  H Stracke; A Schulz; U Weber; J Ullmann; H Schatz
Journal:  Klin Wochenschr       Date:  1987-11-16

8.  Serum osteocalcin and total body calcium in normal pre- and postmenopausal women and postmenopausal osteoporotic patients.

Authors:  S Yasumura; J F Aloia; C M Gundberg; J Yeh; A N Vaswani; K Yuen; A F Lo Monte; K J Ellis; S H Cohn
Journal:  J Clin Endocrinol Metab       Date:  1987-04       Impact factor: 5.958

9.  Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease.

Authors:  R J Duda; J F O'Brien; J A Katzmann; J M Peterson; K G Mann; B L Riggs
Journal:  J Clin Endocrinol Metab       Date:  1988-05       Impact factor: 5.958

10.  Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss.

Authors:  P D Delmas; D Stenner; H W Wahner; K G Mann; B L Riggs
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808
View more
  2 in total

1.  New biochemical markers of bone resorption derived from collagen breakdown in the study of postmenopausal osteoporosis.

Authors:  R Guerrero; M A Diaz Martin; E M Diaz Diego; T Disla; A Rapado; C de la Piedra
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

2.  Appendicular bone density, biochemical markers of bone turnover and lifestyle factors in female teachers of Southern Italy.

Authors:  M Mariconda; M Pavia; A Colonna; I F Angelillo; O Marsico; F Sanzo; C Mancuso; C Milano
Journal:  Eur J Epidemiol       Date:  1997-12       Impact factor: 8.082
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.